CITIC PE-Backed 3SBio Acquires Wansheng Pharma

July 27, 2015 — 10:19 CST

This Data Is Locked!

This area is available only to Subscribers.

Shenyang, Liaoning province-based Chinese bio-pharmaceutical firm 3SBio Inc., backed by CITIC Private Equity Funds Management Co. (CITIC PE), has acquired small molecule manufacturing firm Zhejiang... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Related Data:

China’s Nvidia Contender Cambricon Tech Struggles To Push Chinese-Made AI Chips as It Marks 7th Consecutive Year of Losses

February 9, 2024 — 10:25

Chinese Electric Vehicles Expand Global Reach, Export Growth Surges by 84% Outside China

December 19, 2023 — 00:50

China To Expand Investment Scope for Its National Social Security Fund

December 8, 2023 — 00:03

US’s Top 10 Public Companies Worth Over Five Times Than China’s Top 10

December 21, 2021 — 23:37

China Tech Digest: Tencent Unveils Three Self-developed Chips; Huawei’s Autonomous Driving Unit Founder Joins Zeekr

November 4, 2021 — 09:39

Honda China Collaborates with AutoX on Autonomous Driving Research Through Testing on China’s Public Roads

April 16, 2021 — 21:49

China’s Beidou Satellite System Finds Another Application: Sending Early Warnings For Landslide

March 3, 2021 — 03:17

China, With 1.4 Billion People, Faces Looming Demographic Crisis

February 18, 2021 — 04:48

Labor Dispute Soars At Chinese Tech Giants Driven By Insufficient Innovation, Competition

February 16, 2021 — 03:20